Literature DB >> 17659597

Metabolic correlates of nonalcoholic fatty liver in women and men.

Gloria Lena Vega1, Manisha Chandalia, Lidia S Szczepaniak, Scott M Grundy.   

Abstract

UNLABELLED: Nonalcoholic hepatic steatosis associates with a clustering of metabolic risk factors and steatohepatitis. One risk factor for hepatic steatosis is obesity, but other factors likely play a role. We examined metabolic concomitants of hepatic steatosis in nonobese and obese men and women. Sixty-one obese women and 35 obese men were studied; both those with and without hepatic steatosis were compared against each other and against nonobese controls (17 women and 32 men) without hepatic steatosis. Obesity (defined as >or=25% body fat in men and >or=35% in women), was identified by x-ray absorptiometry, whereas hepatic steatosis (>or=5.5% liver fat) was detected by magnetic resonance spectroscopy. The primary endpoint was a difference in insulin sensitivity. Obese groups with and without steatosis had similar body fat percentages. Compared with obese women without hepatic steatosis, those with steatosis were more insulin resistant; the same was true for men, although differences were less striking. Obese subjects with hepatic steatosis had higher ratios of truncal-to-lower body fat and other indicators of adipose tissue dysfunction compared with obese subjects without steatosis.
CONCLUSION: These results support the concept that obesity predisposes to hepatic steatosis; but in addition, insulin resistance beyond that induced by obesity alone and a relatively high ratio of truncal-to-lower body fat usually combined with obesity to produce an elevated liver fat content.

Entities:  

Mesh:

Year:  2007        PMID: 17659597     DOI: 10.1002/hep.21727

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  Insulin resistance is not associated with myocardial steatosis in women.

Authors:  M Krššák; Y Winhofer; C Göbl; M Bischof; G Reiter; A Kautzky-Willer; A Luger; M Krebs; C Anderwald
Journal:  Diabetologia       Date:  2011-04-15       Impact factor: 10.122

2.  Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.

Authors:  Janet Wei; Michael D Nelson; Edward W Szczepaniak; Laura Smith; Puja K Mehta; Louise E J Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz; Lidia S Szczepaniak
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-30       Impact factor: 4.733

3.  Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.

Authors:  Kenichi Nishioji; Yoshio Sumida; Mai Kamaguchi; Naomi Mochizuki; Masao Kobayashi; Takeshi Nishimura; Kanji Yamaguchi; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2014-03-12       Impact factor: 7.527

4.  CRTC3 links catecholamine signalling to energy balance.

Authors:  Youngsup Song; Judith Altarejos; Mark O Goodarzi; Hiroshi Inoue; Xiuqing Guo; Rebecca Berdeaux; Jeong-Ho Kim; Jason Goode; Motoyuki Igata; Jose C Paz; Meghan F Hogan; Pankaj K Singh; Naomi Goebel; Lili Vera; Nina Miller; Jinrui Cui; Michelle R Jones; Yii-Der I Chen; Kent D Taylor; Willa A Hsueh; Jerome I Rotter; Marc Montminy
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

5.  Adipose tissue dysfunction in humans: a potential role for the transmembrane protein ENPP1.

Authors:  Manisha Chandalia; Himara Davila; Wentong Pan; Magdalena Szuszkiewicz; Demidmaa Tuvdendorj; Edward H Livingston; Nicola Abate
Journal:  J Clin Endocrinol Metab       Date:  2012-09-25       Impact factor: 5.958

6.  Lean NAFLD: An Underrecognized Outlier.

Authors:  Julia Wattacheril; Arun J Sanyal
Journal:  Curr Hepatol Rep       Date:  2016-04-14

7.  Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.

Authors:  Marianna Argentou; Dina G Tiniakos; Menelaos Karanikolas; Maria Melachrinou; Maria G Makri; Christos Kittas; Fotis Kalfarentzos
Journal:  Obes Surg       Date:  2009-07-15       Impact factor: 4.129

8.  Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.

Authors:  Yasuji Arase; Fumitaka Suzuki; Kenji Ikeda; Hiromitsu Kumada; Hiroshi Tsuji; Tetsuro Kobayashi
Journal:  J Gastroenterol       Date:  2009-06-17       Impact factor: 7.527

9.  Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents.

Authors:  Claudia M Toledo-Corral; Tanya L Alderete; Joyce Richey; Paola Sequeira; Michael I Goran; Marc J Weigensberg
Journal:  Acta Diabetol       Date:  2014-08-11       Impact factor: 4.280

10.  Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.

Authors:  Wolfram Goessling; Joseph M Massaro; Ramachandran S Vasan; Ralph B D'Agostino; R Curtis Ellison; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.